Pharmacokinetics of Raltegravir During Third Trimester Pregnancy and Post-Partum.
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 28 Mar 2012
At a glance
- Drugs Raltegravir (Primary)
- Indications HIV-1 infections; Pregnancy
- Focus Pharmacokinetics
- 28 Mar 2012 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 24 Jun 2008 New trial record.